NCBiotech News

Atox Bio, an Israeli company with U.S. headquarters in Durham, has received FDA acceptance of its new drug application for reltecimod, a drug developed for patients with necrotizing soft-tissue infections.

Xeomin, a botulinum toxin therapy developed by Raleigh-based Merz Therapeutics, has gained yet another new use.

Morrisville immunotherapies developer Heat Biologics is moving closer to human testing of a vaccine for COVID-19.

Dallas-based Taysha Gene Therapies announced plans today to invest $75 million in a gene therapy manufacturing facility in Durham that will employ 201 people over the next three years.

Aaron Lazarus, a Wake Forest University graduate who co-founded EncepHeal Therapeutics, a biotech company in Winston-Salem, has been recognized by Triad Business Journal’s “20 in their 20s” awards honoring young movers and shakers in the 12-county Triad region.

Durham diagnostics company Baebies is winning kudos for its pediatric testing platform that uses one drop of blood to perform quick tests for multiple diseases.

vTv Therapeutics of High Point has out-licensed worldwide development and commercialization rights to its potential kidney disease drug to a California biotech company in a deal that ultimately could be worth more than $150 million.

Durham's BioSkryb is launching a grant program to secure a “breakthrough” in single-cell genomics using its proprietary technology, recently launched commercially as ResolveDNA.

Thermo Fisher Scientific will invest approximately $500 million and add 500 new jobs in Greenville over the next two years as it expands its sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines

Burlington-based LabCorp has received Emergency Use Authorization from the FDA to sell its COVID-19 test home collection kit, the first to be available over the counter without requiring a prescription.

Durham gene editing ag tech leader Elo Life Systems is using its proprietary computational biology pipeline to identify the genetic factors that can improve the vanilla orchid and introduce groundbreaking ways to produce more vanilla with less labor.

Antifungal therapies developer Mycovia is preparing to seek FDA approval of its first drug after the compound posted

Newly released Seqirus data demonstrate the effectiveness and safety of its pandemic influenza A (H5N1) vaccine that it makes in cell culture at its massive manufacturing facility in Holly Springs.

Southeastern North Carolina’s rural Scotland County community of Maxton is getting 10 new jobs and a $1.9 million expansion being added to the local Huvepharma factory, thanks in part to funding from NCBiotech.

Chimerix, a Durham-based biopharmaceutical company that’s developing medicines to treat cancer and other diseases, has received good regulatory news for its potential antiviral treatment for smallpox.